Thema: US6402683063
NKTR, US6402683063
business-21681_1920.jpg - Foto: THN
Nektar Therapeutics stock trades at 34.16 euros late Friday
Nektar Therapeutics stock traded in late Friday activity as investors monitored NKTR. The latest quote provides a fresh reference for the session.
ad-hoc-news.de, heute 20:05 Uhr
NKTR, US6402683063
UBS sets USD 53.00 target for Nektar Therapeutics stock
Revenue was USD 10.13 million versus USD 10.43 million expected. Nektar Therapeutics stock costs EUR 34.15 on October 27, 2026, 2.77 percent above Tradegate close.
ad-hoc-news.de, 27.10.26 21:58 Uhr
NKTR, US6402683063
Nektar Therapeutics stock fell 3.70 percent on Nasdaq on ...
Piper Sandler kept a USD 192.00 target on October 22, 2026. Nektar Therapeutics stock fell 3.70 percent to USD 37.22 on Nasdaq.
ad-hoc-news.de, 24.10.26 19:02 Uhr
NKTR, US6402683063
BTIG keeps USD 178 target for Nektar Therapeutics stock
Nektar guided to USD 815 million to USD 840 million cash at year-end. Nektar Therapeutics stock costs EUR 34.33 on October 20, 2026.
ad-hoc-news.de, 20.10.26 21:52 Uhr
NKTR, US6402683063
Nektar Therapeutics stock trails UBS target by 32.49 percent ...
Second-quarter 2026 revenue was USD 10.13 million. Nektar Therapeutics stock last stood at USD 35.78 on October 16, 2026, down 5.14 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 20:52 Uhr
NKTR, US6402683063
UBS sets USD 53.00 target for Nektar Therapeutics stock
Nektar's market value was USD 1.1 billion on October 15, 2026. Nektar Therapeutics stock costs EUR 33.72 on October 15, 2026 at 9:14 p.m. CEST.
ad-hoc-news.de, 15.10.26 21:22 Uhr
NKTR, US6402683063
Nektar Therapeutics stock faces a cash runway into 2028
Nektar Therapeutics stock was last at USD 40.20 on October 7, 2026. Q2 EPS of negative USD 1.23 beat the consensus loss of negative USD 1.97.
ad-hoc-news.de, 08.10.26 04:15 Uhr
NKTR, US6402683063
Nektar presents durability data and H.C. Wainwright keeps ...
